Hypothalamic mTOR: The Rookie Energy Sensor

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|14|1|3-21

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.14, Iss.1, 2014-01, pp. : 3-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Inhibition and the Tumor Vasculature

By  

Current Angiogenesis, Vol. 1, Iss. 1, 2012-04 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

The limitations of calcineurin and mTOR inhibitors: new directions for immunosuppressive strategies

By Kahan B.D.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 130-133

Elsevier

Access to resources Recommend Favorite

PI 3-kinase, mTOR, protein synthesis and cancer

By Vogt P.K.  

Trends in Molecular Medicine, Vol. 7, Iss. 11, 2001-11 ,pp. : 482-484

Elsevier

Access to resources Recommend Favorite

A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL

By Decker Thomas  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 221-227

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma

By  

Current Molecular Medicine, Vol. 15, Iss. 1, 2015-01 ,pp. : 82-93

Bentham Science Publishers

Access to resources Recommend Favorite